Cargando…

The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products

The Neglected Tropical Disease Voucher Program is a Congressionally-mandated program intended to promote approval of products for tropical diseases because it provides spectacular financial compensation consequent to FDA approval of a priority product. Three drug approvals–artemether/lumifantrine fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berman, Jonathan, Radhakrishna, Tanya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2017
Materias:	Perspective Pieces
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239674/ https://www.ncbi.nlm.nih.gov/pubmed/27573627 http://dx.doi.org/10.4269/ajtmh.16-0099

Ejemplares similares

Priorities for the Priority Review Voucher
por: Ridley, David B.
Publicado: (2017)

Ten Years of Universal Testing: How the Rapid Diagnostic Test Became a Game Changer for Malaria Case Management and Improved Disease Reporting
por: Aidoo, Michael, et al.
Publicado: (2022)

Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19?
por: Gutman, Julie R., et al.
Publicado: (2020)

Integrating Neglected Tropical Disease and Immunization Programs: The Experiences of the Tanzanian Ministry of Health
por: Mwingira, Upendo John, et al.
Publicado: (2016)

Presidential Address: Tropical Medicine in War and Peace
por: Plowe, Christopher V.
Publicado: (2016)

Emerging Trends in Clinical Tropical Medicine Research
por: Huntington, Mark K., et al.
Publicado: (2019)

The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
por: Aerts, Celine, et al.
Publicado: (2022)

Compassionate Leadership: Essential for the Future of Tropical Medicine and Global Health
por: Harrel, Evan, et al.
Publicado: (2021)

President’s Address (November 2016): American Society of Tropical Medicine and Hygiene
por: Higgs, Stephen
Publicado: (2017)

Correction to: The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
por: Aerts, Celine, et al.
Publicado: (2022)

Reducing the Carbon Footprint of Academic Conferences: The Example of the American Society of Tropical Medicine and Hygiene
por: Bousema, Teun, et al.
Publicado: (2020)

Is the priority review voucher program stimulating new drug development for tropical diseases?
por: Kerr, Kirk W., et al.
Publicado: (2018)

Clara Southmayd Ludlow: Her Thirst for Knowledge was Positively Inspirational: Honoring a Female Giant in Tropical Medicine
por: Higgs, Stephen, et al.
Publicado: (2017)

Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic Regions
por: Koita, Ousmane A., et al.
Publicado: (2016)

Ebola Outbreak amid COVID-19 in the Republic of Guinea: Priorities for Achieving Control
por: Aborode, Abdullahi Tunde, et al.
Publicado: (2021)

Responding to the Challenge of the Dual COVID-19 and Ebola Epidemics in the Democratic Republic of Congo—Priorities for Achieving Control
por: Nachega, Jean B., et al.
Publicado: (2020)

Priority Review Vouchers: GAO Report Provides Scant Evidence of Success
por: Meyer, Robert J.
Publicado: (2020)

Transoral Thyroidectomy: Is It a Real Game Changer?
por: Tae, Kyung
Publicado: (2020)

Emerging Filoviral Disease in Uganda: Proposed Explanations and Research Directions
por: Polonsky, Jonathan A., et al.
Publicado: (2014)

Can Anaerobic Soil Disinfestation (ASD) be a Game Changer in Tropical Agriculture?
por: Priyashantha, A. K. Hasith, et al.
Publicado: (2021)

Dogma in Classifying Dengue Disease
por: Farrar, Jeremy J., et al.
Publicado: (2013)

Combatting the Increasing Threat of Vector-Borne Disease in the United States with a National Vector-Borne Disease Prevention and Control System
por: Petersen, Lyle R., et al.
Publicado: (2019)

GeneXpert—A Game-Changer for Tuberculosis Control?
por: Evans, Carlton A.
Publicado: (2011)

Could Digital Therapeutics be a Game Changer in Psychiatry?
por: Cho, Chul-Hyun, et al.
Publicado: (2019)

Logistics of Guinea Worm Disease Eradication in South Sudan
por: Jones, Alexander H., et al.
Publicado: (2014)

Being Ready to Treat Ebola Virus Disease Patients
por: Brett-Major, David M., et al.
Publicado: (2015)

Mosquito-Borne Human Viral Diseases: Why Aedes aegypti?
por: Powell, Jeffrey R.
Publicado: (2018)

Keynote Address (November 2016): Zika Virus Disease in the Americas: A Storm in the Making
por: Etienne, Carissa, et al.
Publicado: (2017)

Consequences of Pathogen Lists: Why Some Diseases May Continue to Plague Us
por: Brett-Major, David M., et al.
Publicado: (2019)

Transmission-Blocking Preventive Measures for Infectious Diseases: Altruism, Solidarity, and the Common Good
por: Garber, Laine, et al.
Publicado: (2021)

Insights into the Use of C-Reactive Protein as a Diagnostic Index of Disease Severity in COVID-19 Infections
por: Potempa, Lawrence A., et al.
Publicado: (2020)

Analysis of Neglected Tropical Disease Drug and Vaccine Development Pipelines to Predict Issuance of FDA Priority Review Vouchers over the Next Decade
por: Stefanakis, Rianna, et al.
Publicado: (2012)

A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19)
por: Keshtkar-Jahromi, Maryam, et al.
Publicado: (2020)

The Impact of Ken Warren’s Leadership of the Rockefeller Foundation’s Great Neglected Diseases Program on the Future of Malaria Research
por: Miller, Louis H.
Publicado: (2017)

Advanced Preparation Makes Research in Emergencies and Isolation Care Possible: The Case of Novel Coronavirus Disease (COVID-19)
por: Brett-Major, David M., et al.
Publicado: (2020)

How Is the World Responding to the Novel Coronavirus Disease (COVID-19) Compared with the 2014 West African Ebola Epidemic? The Importance of China as a Player in the Global Economy
por: Maffioli, Elisa M.
Publicado: (2020)

Recommendations for the COVID-19 Response at the National Level Based on Lessons Learned from the Ebola Virus Disease Outbreak in the Democratic Republic of the Congo
por: Mobula, Linda Meta, et al.
Publicado: (2020)

Venetoclax: a real game changer in treatment of chronic lymphocytic leukemia
por: Molica, Stefano
Publicado: (2020)

The WHO fungal priority pathogens list as a game-changer
por: Fisher, Matthew C., et al.
Publicado: (2023)

Ebola Policies That Hinder Epidemic Response by Limiting Scientific Discourse
por: Asgary, Ramin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qckoho3dko88pm2vgtnl2ivlr0